Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us

Download Mobile App




Blood Gas Analyzer Enhances Diagnostic Testing

By LabMedica International staff writers
Posted on 01 Nov 2011
The latest cartridge-based analyzer for critical care testing has been introduced offering new features designed for ease-of-use at the point of care (POC). More...


The blood gas analyzer will aid clinicians who are increasingly relying on critical-care tests, such as blood gases, to deliver fast, accurate results to help guide treatment decisions.

The RAPIDPoint 500 analyzer offers a comprehensive menu of critical-care tests for pH and blood gases, electrolytes, glucose and lactate1 and full carbon monoxide (CO)-oximetry, including neonatal total bilirubin and total hemoglobin, all from a single, whole-blood sample. The results are obtained in approximately 60 seconds. Additionally, the measurement cartridges last up to 28 days and contain a full complement of tests, which reduces downtime.

Equipped with fully automated calibration and Quality Control (QC), the RAPIDPoint 500 system (Siemens Healthcare Diagnostics; Erlangen, Germany) is also designed to help POC professionals satisfy organizational and regulatory compliance requirements. The self-contained Automatic Quality Control (AQC) cartridges operate without manual intervention, helping reduce POC staff’s administrative tasks. An integrated bar code reader conveniently located on the front of the system offers a wide scanning area to accommodate patient and operator identification to ensure overall data entry integrity.

Hilda Crockett, the business manager for Point of Care at Siemens Healthcare Diagnostics, said, “The RAPIDPoint 500 system is designed to satisfy the unique demands of testing at the point of care. In addition to being easy-to-use, the analyzer leverages proven and reliable cartridge-based technologies to deliver fast, accurate, laboratory-quality results, helping clinicians feel confident in making critical decisions that impact patient lives.”

Related Links:

Siemens Healthcare Diagnostics




Gold Member
Blood Gas Analyzer
Stat Profile pHOx
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gold Member
Collection and Transport System
PurSafe Plus®
8-Channel Pipette
SAPPHIRE 20–300 µL
Read the full article by registering today, it's FREE! It's Free!
Register now for FREE to LabMedica.com and get access to news and events that shape the world of Clinical Laboratory Medicine.
  • Free digital version edition of LabMedica International sent by email on regular basis
  • Free print version of LabMedica International magazine (available only outside USA and Canada).
  • Free and unlimited access to back issues of LabMedica International in digital format
  • Free LabMedica International Newsletter sent every week containing the latest news
  • Free breaking news sent via email
  • Free access to Events Calendar
  • Free access to LinkXpress new product services
  • REGISTRATION IS FREE AND EASY!
Click here to Register








Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more
Copyright © 2000-2026 Globetech Media. All rights reserved.